J Neurol Surg A Cent Eur Neurosurg 2023; 84(04): 321-328
DOI: 10.1055/s-0041-1739207
Original Article

Oxidative Stress Level in Patients with Subarachnoid Hemorrhage

1   Department of Neurosurgery, Aile Hospital, Istanbul, Turkey
,
2   Department of Medical Biochemistry, Hamidiye School of Medicine, University of Health Sciences, Istanbul, Turkey
3   Department of Medical Biochemistry, Haydarpasa Numune Health Application and Research Center, Hamidiye Faculty of Medicine, University of Health Sciences, Istanbul, Turkey
,
1   Department of Neurosurgery, Aile Hospital, Istanbul, Turkey
,
4   Department of Neurosurgery, Bezmialem Vakif University, Istanbul, Turkey
,
4   Department of Neurosurgery, Bezmialem Vakif University, Istanbul, Turkey
,
5   Department of Biochemistry, Bezmialem Vakif University, Istanbul, Turkey
,
6   Department of Radiology, Bezmialem Vakif University, Istanbul, Turkey
,
4   Department of Neurosurgery, Bezmialem Vakif University, Istanbul, Turkey
› Author Affiliations
Funding This study was supported by Bezmialem Vakif University Scientific Research Projects Unit (BAP Project Number: 18245212-108.99).

Abstract

Background One of the antioxidant mechanisms is the dynamic balance between thiol and disulfide, which, in subarachnoid hemorrhage and other chronic diseases, is disrupted in favor of the latter. The two most commonly used oxidative stress (OS) biochemical markers are the oxidative stress index (OSI) value, which indicates the total oxidant status (TOS) and total antioxidant status (TAS) balance, and the thiol–disulfide (TDS) value, which indicates the total thiol (TT) and native thiol (NT) balance. High OS levels require further investigations. We aimed to investigate the OS level in aneurysmal SAH (aSAH) patients.

methods In this clinical prospective study, blood samples were collected from 50 consecutively treated patients with aSAH and 50 volunteers. Serum TOS, TAS, TT, and NT levels were measured using Erel's method via a spectrophotometer. The Glasgow Coma Scale (GCS) scores, Fisher grades, length of hospital stay (LOS), and the Glasgow Outcome Scale (GOS) scores were recorded. Consequently, the OSI and TDS values were calculated in all participants.

Results A statistically significant difference was observed in the TAS, TOS, OSI, and TDS values between the aSAH patients and the controls. The TT and NT values were significantly lower in aSAH patients than in the controls. A correlation was identified between the OSI values and the GCS scores. Although a correlation was observed between the TDS values and the LOS, no correlation was found between the OSI and the TDS values.

Conclusion The OSI and TDS, which are OS indicators, might serve as the additional objective nominal data to evaluate the treatment efficacy and follow-up for SAH patients. Moreover, decreasing the OSI values and increasing the TT values can be used as improvement indicators in the treated aSAH patients. If we can reduce the OS at the early stage of SAH, it could improve the prognosis by reducing both the morbidity and mortality rates. Further randomized investigations are required to prove the findings in this prospective study.

Statement of Authorship

AA was responsible for conceptualization, methodology, software, supervision, formal analysis, literature review, visualization, investigation, writing and review of the original draft, and statistical analysis. İÇ performed the literature review and formal analysis and was involved in writing and reviewing of the original draft. EMG was in responsible for supervision and methodology of the study. MGP, SY, and IY were responsible for validation, whereas OFO was responsible for the methodology. TTD was involved with conceptualization, software, and supervision (TTD is a senior author for the study).


Note

This prospective study was approved by Bezmialem Vakif University ethical board under decision number 2018.876.




Publication History

Received: 18 September 2020

Accepted: 14 May 2021

Article published online:
12 December 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • Reference

  • 1 Asiltürk M, Abdallah A. Clinical outcomes of multiple aneurysms microsurgical clipping: evaluation of 90 patients. Neurol Neurochir Pol 2018; 52 (01) 15-24
  • 2 Dundar TT, Abdallah A, Yurtsever I, Guler EM, Ozer OF, Uysal O. Serum SUR1 and TRPM4 in patients with subarachnoid hemorrhage. Neurosurg Rev 2020; 43 (06) 1595-1603
  • 3 Hoffman WE, Wheeler P, Edelman G, Charbel FT, Torres NJ, Ausman JI. Hypoxic brain tissue following subarachnoid hemorrhage. Anesthesiology 2000; 92 (02) 442-446
  • 4 Ayer RE, Zhang JH. Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. Acta Neurochir Suppl (Wien) 2008; 104: 33-41
  • 5 Han Y, Zhang T, Su J. et al. Apigenin attenuates oxidative stress and neuronal apoptosis in early brain injury following subarachnoid hemorrhage. J Clin Neurosci 2017; 40: 157-162
  • 6 Ransohoff RM, Schafer D, Vincent A, Blachère NE, Bar-Or A. Neuroinflammation: ways in which the immune system affects the brain. Neurotherapeutics 2015; 12 (04) 896-909
  • 7 Akkaya E, Evran Ş, Çalış F. et al. Effects of intrathecal verapamil on cerebral vasospasm in experimental rat study. World Neurosurg 2019; 127: e1104-e1111
  • 8 Matz PG, Fujimura M, Lewen A, Morita-Fujimura Y, Chan PH. Increased cytochrome c-mediated DNA fragmentation and cell death in manganese-superoxide dismutase-deficient mice after exposure to subarachnoid hemolysate. Stroke 2001; 32 (02) 506-515
  • 9 Sies H, Berndt C, Jones DP. Oxidative stress. Annu Rev Biochem 2017; 86 (01) 715-748
  • 10 Yu W, Kavi T, Majic T. et al. Treatment modality and quality benchmarks of aneurysmal subarachnoid hemorrhage at a comprehensive stroke center. Front Neurol 2018; 9: 152
  • 11 Starke RM, Chalouhi N, Ali MS. et al. The role of oxidative stress in cerebral aneurysm formation and rupture. Curr Neurovasc Res 2013; 10 (03) 247-255
  • 12 Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38 (12) 1103-1111
  • 13 Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 2014; 47 (18) 326-332
  • 14 Modi S, Shah K, Schultz L, Tahir R, Affan M, Varelas P. Cost of hospitalization for aneurysmal subarachnoid hemorrhage in the United States. Clin Neurol Neurosurg 2019; 182: 167-170
  • 15 Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H, LLeonart ME. Oxidative stress and cancer: an overview. Ageing Res Rev 2013; 12 (01) 376-390
  • 16 Fumoto T, Naraoka M, Katagai T, Li Y, Shimamura N, Ohkuma H. The role of oxidative stress in microvascular disturbances after experimental subarachnoid hemorrhage. Transl Stroke Res 2019; 10 (06) 684-694
  • 17 Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160 (01) 1-40
  • 18 Kaynar MY, Tanriverdi T, Kemerdere R, Atukeren P, Gumustas K. Cerebrospinal fluid superoxide dismutase and serum malondialdehyde levels in patients with aneurysmal subarachnoid hemorrhage: preliminary results. Neurol Res 2005; 27 (05) 562-567
  • 19 Gumusyayla S, Vural G, Bektas H, Deniz O, Neselioglu S, Erel O. A novel oxidative stress marker in patients with Alzheimer's disease: dynamic thiol-disulphide homeostasis. Acta Neuropsychiatr 2016; 28 (06) 315-320
  • 20 Ghezzi P, Bonetto V, Fratelli M. Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation. Antioxid Redox Signal 2005; 7 (7–8): 964-972
  • 21 Figueroa S, Oset-Gasque MJ, Arce C, Martinez-Honduvilla CJ, González MP. Mitochondrial involvement in nitric oxide-induced cellular death in cortical neurons in culture. J Neurosci Res 2006; 83 (03) 441-449
  • 22 Naoi M, Maruyama W, Shamoto-Nagai M, Yi H, Akao Y, Tanaka M. Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders. Mol Neurobiol 2005; 31 (1–3): 81-93
  • 23 Abdallah A, Asiltürk M, Emel E, Abdallah BG. Factors affecting the outcomes of multiple intracranial aneurysm surgery. Indian J Neurosurg. 2018; 7 (02) 116-121
  • 24 Abdallah A. Letter to the editor regarding “Increasing frailty predicts worse outcomes and increased complications following angiogram-negative subarachnoid hemorrhages.”. World Neurosurg 2020; 134: 674-675